Lidocaine protects from myocardial damage due to ischemia and reperfusion in mice by its antiapoptotic effects

Anesthesiology

Volumn 110, Issue 5, 2009, Pages 1041-1049

  Kaczmarek, Dominik J ^a   Herzog, Christine ^b   Larmann, Jan ^b   Gillmann, Hans Jörg ^a   Hildebrand, Reinhard ^a   Schmitz, Martina ^a   Westermann, Anik ^b   Harendza, Thomas ^b   Werdehausen, Robert ^d   Osthaus, Alexander W ^b   Echtermeyer, Frank ^b   Hahnenkamp, Klaus ^a   Wollert, Kai C ^c   Theilmeier, Gregor ^b,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Department of Anesthesiology and Intensive Care Medicine ^*  (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; HISTONE; LIDOCAINE; CARDIOTONIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DENSITY; CELL HYPOXIA; CELL INTERACTION; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE MODEL; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE MIGRATION; MOUSE; NEUTROPHIL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; REOXYGENATION; REPERFUSION INJURY; TREATMENT OUTCOME; ANIMAL; COMPARATIVE STUDY; HEART MUSCLE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; LIDOCAINE; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM;

EID: 65549102900     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31819dabda     Document Type: Article

References (44)

1. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW: Myocardial infarction after noncardiac surgery. ANESTHESIOLOGY 1998; 88:572-8
2. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Asso ciation Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in collaboration with the American Society of Echocardiography American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418-99
3. BlankesteijnWM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, Smits JF Dynamics of cardiac wound healing following myocardial infarction: Observations in genetically altered mice. Acta Physiol Scand 2001; 173:75-82
4. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D Daemen MJ, Carmeliet P: Inhibition of plasminogen activators or matrix metal loproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999; 5:1135-42
5. Vinten-Johansen J: Involvement of neutrophils in the pathogenesis of letha myocardial reperfusion injury. Cardiovasc Res 2004; 61:481-97
6. Hahnenkamp K, Theilmeier G, Van Aken HK, Hoenemann CW: The effect of local anesthetics on perioperative coagulation, inammation, and microcircu lation. Anesth Analg 2002; 94:1441-7
7. Hollmann MW, Durieux ME: Local anesthetics and the inammatory response: A new therapeutic indication? ANESTHESIOLOGY 2000; 93:858-75
8. Nasser FN, Walls JT, Edwards WD, Harrison CE Jr: Lidocaine-induced reduction in size of experimental myocardial infarction. Am J Cardiol 1980;46:967-75
9. Ebel D, Lipfert P, Frassdorf J, Preckel B, Mullenheim J, Thamer V, Schlack W: Lidocaine reduces ischaemic but not reperfusion injury in isolated rat heart Br J Anaesth 2001; 86:846-52
10. Lee R, Nitta T, Schmid RA, Schuessler RB, Harris KM, Gay WA Jr: Retro grade infusion of lidocaine or L-arginine before reperfusion reduces myocardia infarct size. Ann Thorac Surg 1998; 65:1353-9
11. Conway EM, Van deWouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeie G: The lectin-like domain of thrombomodulin confers protection from neutro phil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 2002; 196:565-77
12. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R Schulz R, Heusch G, Haude M, vonWnuck Lipinski K, Herzog C, Schmitz M, Erbe R, Chun J, Levkau B: High-density lipoproteins and their constituent, sphingosine 1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006; 114:1403-9
13. Metzler B, Hammerer-Lercher A, Jehle J, Dietrich H, Pachinger O, Xu Q, Mair J: Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction. Clin Chim Acta 2002; 325:87-90
14. Singbartl K, Forlow SB, Ley K: Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. Faseb J 2001;15:2337-44
15. Fiedler B, Feil R, Hofmann F, Willenbockel C, Drexler H, Smolenski A, Lohmann SM, Wollert KC: cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes. J Biol Chem 2006; 281:32831-40
16. Theilmeier G, De Geest B, Van Veldhoven PP, Stengel D, Michiels C, Lox M, Landeloos M, Chapman MJ, Ninio E, Collen D, Himpens B, Holvoet P: HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice. Faseb J 2000; 14:2032-9
17. Faul F, Erdfelder E, Lang AG, Buchner A: G Power 3: A exible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39:175-91
18. Butwell NB, Ramasamy R, Lazar I, Sherry AD, Malloy CR: Effect of lidocaine on contracture, intracellular sodium, and pH in ischemic rat hearts. Am J Physiol 1993; 264:H1884-9
19. Cook VL, Jones Shults J, McDowell M, Campbell NB, Davis JL, Blikslager AT: Attenuation of ischaemic injury in the equine jejunum by administration of systemic lidocaine. Equine Vet J 2008; 40:353-7
20. Fischer LG, Bremer M, Coleman EJ, Conrad B, Krumm B, Gross A, Hollmann MW, Mandell G, Durieux ME: Local anesthetics attenuate lysophosphatidic acid-induced priming in human neutrophils. Anesth Analg 2001; 92:1041-7
21. Zhang XW, Thorlacius H: Inhibitory actions of ropivacaine on tumor necrosis factor-alpha-induced leukocyte adhesion and tissue accumulation in vivo. Eur J Pharmacol 2000; 392:R1-3
22. Gallos G, Jones DR, Nasr SH, Emala CW, Lee HT: Local anesthetics reduce mortality and protect against renal and hepatic dysfunction in murine septic peritonitis. ANESTHESIOLOGY 2004; 101:902-11
23. Lan W, Harmon D, Wang JH, Shorten G, Redmond P: The effect of lidocaine on neutrophil CD11b/CD18 and endothelial ICAM-1 expression and IL-1beta concentrations induced by hypoxia-reoxygenation. Eur J Anaesthesiol 2004; 21:967-72
24. Li CY, Tsai CS, Hsu PC, Chueh SH, Wong CS, Ho ST: Lidocaine attenuates monocyte chemoattractant protein-1 production and chemotaxis in human monocytes: Possible mechanisms for its effect on inammation. Anesth Analg 2003; 97:1312-6
25. Martinsson T, Oda T, Fernvik E, Roempke K, Dalsgaard CJ, Svensjo E: Ropivacaine inhibits leukocyte rolling, adhesion and CD11b/CD18 expression. J Pharmacol Exp Ther 1997; 283:59-65
26. MacGregor RR, Thorner RE, Wright DM: Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inammatory sites. Blood 1980;56:203-9
27. Honemann CW, Arledge JA, Podranski T, Aken HV, Durieux M: Volatile and local anesthetics interfere with thromboxane A2 receptors recombinantly expressed in Xenopus oocytes. Adv Exp Med Biol 1999; 469:277-83
28. Theilmeier G, Lenaerts T, Remacle C, Collen D, Vermylen J, Hoylaerts MF: Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. Blood 1999; 94:2725-34
29. Ross JD, Ripper R, Law WR, Massad M, Murphy P, Edelman L, Conlon B, Feinstein DL, Palmer JW, DiGregorio G, Weinberg GL: Adding bupivacaine to high-potassium cardioplegia improves function and reduces cellular damage of rat isolated hearts after prolonged, cold storage. ANESTHESIOLOGY 2006; 105:746-52
30. Lei B, Popp S, Capuano-Waters C, Cottrell JE, Kass IS: Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats. Neuroscience 2004; 125:691-701
31. Das KC, Misra HP: Lidocaine: A hydroxyl radical scavenger and singlet oxygen quencher. Mol Cell Biochem 1992; 115:179-85
32. Herroeder S, Pecher S, Schonherr ME, Kaulitz G, Hahnenkamp K, Friess H, Bottiger BW, Bauer H, Dijkgraaf OG, Durieux ME, Hollmann MW: Systemic lidocaine shortens length of hospital stay after colorectal surgery: A double-blinded, randomized, placebo-controlled trial. Ann Surg 2007; 246:192-200
33. Scholz A, Kuboyama N, Hempelmann G, Vogel W: Complex blockade of TTX-resistant Na currents by lidocaine and bupivacaine reduce firing frequency in DRG neurons. J Neurophysiol 1998; 79:1746-54
34. de Jong RH, Bonin JD: Deaths from local anesthetic-induced convulsions in mice. Anesth Analg 1980; 59:401-5
35. de Jong RH, Bonin JD: Mixtures of local anesthetics are no more toxic than the parent drugs. ANESTHESIOLOGY 1981; 54:177-81
36. Boselli E, Duo F, Debon R, Allaouchiche B, Chassard D, Thomas L, Portoukalian J: The induction of apoptosis by local anesthetics: A comparison between lidocaine and ropivacaine. Anesth Analg 2003; 96:755-6
37. Friederich P, Schmitz TP: Lidocaine-induced cell death in a human model of neuronal apoptosis. Eur J Anaesthesiol 2002; 19:564-70
38. Johnson ME, Uhl CB, Spittler KH, Wang H, Gores GJ: Mitochondrial injury and caspase activation by the local anesthetic lidocaine. ANESTHESIOLOGY 2004;101:1184-94
39. Kamiya Y, Ohta K, Kaneko Y: Lidocaine-induced apoptosis and necrosis in U937 cells depending on its dosage. Biomed Res 2005; 26:231-9
40. Lee HT, Xu H, Siegel CD, Krichevsky IE: Local anesthetics induce human renal cell apoptosis. Am J Nephrol 2003; 23:129-39
41. Werdehausen R, Braun S, Essmann F, Schulze-Osthoff K, Walczak H, Lipfert P, Stevens MF: Lidocaine induces apoptosis via the mitochondrial path-way independently of death receptor signaling. ANESTHESIOLOGY 2007; 107:136-43
42. Barthel H, Ebel D, Mullenheim J, Obal D, Preckel B, Schlack W: Effect of lidocaine on ischaemic preconditioning in isolated rat heart. Br J Anaesth 2004;93:698-704
43. Yan M, Chen C, Zhang F, Chen G: Lidocaine abolishes the myocardial protective effect of sevourane post-conditioning. Acta Anaesthesiol Scand 2008;52:111-6
44. Ross S, Foex P: Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999; 82:622-32